READ. SCROLL. LISTEN.

Original briefings. Zero spin.

Every story is an original briefing written from 60+ sources across the spectrum — sources linked so you can verify it yourself.

← Back to headlines

Federal Courts Split Over Who Controls the WPATH Litigation as Florida and Texas Cases Collide

Federal Courts Split Over Who Controls the WPATH Litigation as Florida and Texas Cases Collide
Three separate legal battles over transgender medical organizations are moving through federal courts simultaneously, with judges in Illinois, Texas, and Washington D.C. each staking out jurisdiction. Florida's attorney general sued WPATH, the Endocrine Society, and the American Academy of Pediatrics in December for alleged deceptive practices, only to get blocked by a federal judge in Illinois. Meanwhile, a Texas judge paused a Trump administration FTC hearing this week after a parallel D.C. lawsuit complicated the picture.

Three Courts, One Fight

Florida Attorney General James Uthmeier filed suit in December 2025 against the World Professional Association for Transgender Health, the Endocrine Society, and the American Academy of Pediatrics, alleging violations of Florida statutes covering deceptive practices, racketeering, and monopolies. His core argument: these organizations have financial incentives to promote irreversible medical procedures for minors despite limited evidence of benefit and documented harms.

The Department of Health and Human Services concluded there is little evidence of positive outcomes from transgender medical interventions on minors and identified multiple documented harms, according to the Daily Signal's coverage of Uthmeier's complaint.

The AAP, headquartered in Illinois, did not wait for a Florida ruling. It filed a preemptive lawsuit in Illinois federal court, claiming Uthmeier's action was unlawful retaliation against its First Amendment rights.

The Illinois Injunction

U.S. District Judge Matthew F. Kennelly, a Bill Clinton appointee in Illinois, agreed with AAP. He ruled that Uthmeier acted in bad faith and issued a temporary injunction blocking the Florida state court lawsuit from proceeding.

Uthmeier appealed. Two of the three judges on a 7th Circuit panel upheld Kennelly's ruling.

The legal basis matters here. Under Younger v. Harris (1971), the Supreme Court held that federal courts should generally stay out of ongoing state proceedings, with a narrow exception for proceedings motivated by harassment or bad faith. Kennelly applied that exception. Uthmeier's position is that a state attorney general filing a civil enforcement action under state law cannot plausibly be characterized as bad faith, and that applying Younger's exception this broadly represents a significant departure from its intended scope.

Federal courts routinely invoke comity to avoid interfering with state proceedings. Using a federal court in Illinois to block a state attorney general's lawsuit filed in Florida state court is an aggressive application of Younger's bad-faith carve-out.

The Texas Pause

Separately, the Federal Trade Commission, joined by the attorneys general of Texas and Iowa, filed its own lawsuit against WPATH in the Northern District of Texas. The FTC pushed for an emergency hearing before U.S. District Judge Reed O'Connor, a George W. Bush appointee, scheduled for July 7.

WPATH simultaneously filed a related lawsuit in Washington D.C., before Chief Judge James Boasberg of the U.S. District Court for the District of Columbia, challenging the FTC's earlier investigative demand.

The FTC asked O'Connor to bar WPATH from seeking relief in any court other than his court, the 5th Circuit, or the Supreme Court, according to Law Dork, which first reported the development. That would have effectively shut down WPATH's D.C. case.

O'Connor declined. He canceled the July 7 hearing and said he would wait for Boasberg to rule first on WPATH's D.C. challenge, according to The Advocate's coverage. O'Connor, who has a documented record of ruling in favor of conservative legal challenges, chose not to be the instrument for boxing WPATH into a single venue.

The Texas Children's Hospital Settlement

This courtroom maneuvering is happening against a backdrop of concrete institutional change. In May, the Department of Justice announced Texas Children's Hospital in Houston agreed to pay $10 million and create what the government described as the nation's first "detransition clinic" to settle federal claims of illegal billing for gender-affirming care for minors.

The hospital disputed the framing. In a statement cited by USA Today, Texas Children's said it had been "compliant with all laws" and characterized the settlement as a pragmatic choice: "We are settling to protect our resources from endless and costly litigation."

As part of the settlement, the hospital agreed to terminate five doctors who provided gender transition procedures to minors and to maintain a list of potential gender-affirming care patients, according to multiple media outlets.

The Fairest Objection

Critics of the government's approach make a legitimate point. They argue that WPATH, the Endocrine Society, and the AAP are mainstream professional organizations whose clinical guidelines represent the considered consensus of tens of thousands of medical professionals, not fringe actors operating in bad faith. From this view, state attorneys general and federal regulators are using litigation and funding threats to override medical judgment with political judgment, chilling the ability of doctors to provide care they believe is appropriate and exposing professional organizations to legal liability simply for publishing guidelines.

Seventeen months of federal pressure have caused more than 40 hospitals to halt or pause some portion of youth gender care services, according to STAT. The institutional retreat is documented regardless of one's view of whether that care is appropriate.

The counter: financial conflicts of interest in medical guideline development are a documented and serious problem across specialties, not a conspiracy theory. The HHS conclusion about limited evidence of benefit is part of the government record. And the mechanisms Uthmeier is using, state consumer protection and anti-deception statutes, are standard enforcement tools applied to other medical industries. Whether they apply here is legitimately contested. That it is improper to even ask the question is a harder position to defend.

What Comes Next

The D.C. lawsuit before Judge Boasberg is now the immediate choke point. His ruling on WPATH's challenge to the FTC's investigative demand will determine whether the Texas proceedings resume and how much legal leverage the administration retains. No timeline for that ruling has been publicly announced as of July 10, 2026.

Sources used for this briefing

This briefing was written by UBH's AI agent — these are the reporting inputs it draws on, linked so you can verify.

right
Daily SignalRobed Tyrants Abuse the Law to Shield Pro-Transgender Medical Charlatans From Accountability
unknown
healthjournalismWhat to know about hospitals' reduction of gender-affirming care for youth
unknown
advocateTrump officials were so extreme in transgender health case that a Texas judge hit pause